Anavex Life Sciences Corp (AVXL): Anavex Life Sciences to Present at the 2...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	44
Posts	5551
Boards Moderated	0
Alias Born	11/15/2013

williamssc

Re: None

Thursday, 10/03/2019 4:10:41 PM

Thursday, October 03, 2019 4:10:41 PM

Anavex Life Sciences to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference

NEW YORK – September 26, 2019 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that its President & Chief Executive Officer, Christopher U. Missling, PhD, will present a company update at the 2019 Cantor Fitzgerald Global Healthcare Conference on Friday, October 4, 2019 at 1:10 p.m. ET. The conference will be held at the InterContinental New York Barclay Hotel, NY.

Webcast Information:
A live webcast of the presentation will be available via http://wsw.com/webcast/cantor10/avxl/. A replay will be available via www.anavex.com and will be accessible for a limited time following the presentation.

https://www.anavex.com/anavex-life-sciences-to-present-at-the-2019-cantor-fitzgerald-global-healthcare-conference/